Activation of mitochondrial ATP‐sensitive potassium channels increases cell viability against rotenone‐induced cell death

We recently showed that activation of ATP‐sensitive potassium (KATP) channels in PC12 cells induces protection against the neurotoxic effect of rotenone, a mitochondrial complex I inhibitor. In this study, we sought to determine the locus of the KATP channels that mediate this protection in PC12 cells. We found that pretreatment of PC12 cells with diazoxide, a mitochondrial KATP channel selective opener, dose‐dependently increases cell viability against rotenone‐induced cell death as indicated in trypan blue exclusion assays. The protective effect of this preconditioning is attenuated by 5‐hydroxydecanoic acid (5‐HD), a selective mitochondrial KATP channel antagonist but not in the presence of HMR‐1098, a selective plasma membrane KATP potassium channel antagonist. In contrast, P‐1075, a selective plasma membrane KATP channel opener, does not induce protection. Using specific antibodies against SUR1 and Kir6.1, we detected immunoreactive proteins of apparent molecular masses 155 and 50 kDa, corresponding to those previously reported for SUR1 and Kir6.1, respectively, in the mitochondria‐enriched fraction of PC12 cells. In addition, whole cell patch‐clamp studies revealed that inward currents in PC12 cells are insensitive to P‐1075, HMR‐1098, glibenclamide and diazoxide, indicating that functional plasma membrane KATP channels are negligible. Taken together, our results demonstrate for the first time that activation of mitochondrial KATP channels elicits protection against rotenone‐induced cell death.

[1]  E. Rojas,et al.  Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. , 2000, European journal of pharmacology.

[2]  C. Culmsee,et al.  Neuronal apoptosis in Alzheimer ’ s disease , 2001 .

[3]  Yongge Liu,et al.  Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels. , 1999, Molecular pharmacology.

[4]  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Lazdunski,et al.  Galanin inhibits dopamine secretion and activates a potassium channel in pheochromocytoma cells , 1989, Brain Research.

[6]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[7]  K. Mikoshiba,et al.  ‘Ischemic tolerance’ phenomenon found in the brain , 1990, Brain Research.

[8]  G. Grover,et al.  Role of Myocardial ATP‐Sensitive Potassium Channels in Mediating Preconditioning in the Dog Heart and Their Possible Interaction With Adenosine A1‐Receptors , 1992, Circulation.

[9]  R. Houghten,et al.  An N-methyl-d-aspartate receptor channel blocker with neuroprotective activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Szewczyk,et al.  The mitochondrial sulfonylurea receptor: identification and characterization. , 1997, Biochemical and biophysical research communications.

[11]  E. Marbán,et al.  Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. , 2000, Circulation.

[12]  F. Ashcroft,et al.  Metabolic inhibition and low internal ATP activate K-ATP channels in rat dopaminergic substantia nigra neurones , 1995, Pflügers Archiv.

[13]  D. Truong,et al.  Activation of adenosine triphosphate‐sensitive potassium channels confers protection against rotenone‐induced cell death: Therapeutic implications for Parkinson's disease , 2002, Journal of neuroscience research.

[14]  E. Nevo,et al.  Reciprocal regulation of expression of pore‐forming KATP channel genes by hypoxia , 2001, Molecular and Cellular Biochemistry.

[15]  F. Ashcroft,et al.  Properties and functions of ATP-sensitive K-channels. , 1990, Cellular signalling.

[16]  G. Grover Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. , 1997, Canadian journal of physiology and pharmacology.

[17]  K. Kunjilwar,et al.  Association and Stoichiometry of KATP Channel Subunits , 1997, Neuron.

[18]  A. Terzic,et al.  Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. , 1998, American journal of physiology. Heart and circulatory physiology.

[19]  M. Smith,et al.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.

[20]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[21]  K. Tai,et al.  Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. , 1991, Journal of molecular and cellular cardiology.

[22]  M. Mattson,et al.  Activation of Mitochondrial ATP-Dependent Potassium Channels Protects Neurons against Ischemia-Induced Death by a Mechanism Involving Suppression of Bax Translocation and Cytochrome c Release , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  S. Seino,et al.  Kir6.1: a possible subunit of ATP-sensitive K+ channels in mitochondria. , 1997, Biochemical and biophysical research communications.

[24]  V. Kupriyanov,et al.  Effects of KATP Channel Openers, P-1075, Pinacidil, and Diazoxide, on Energetics and Contractile Function in Isolated Rat Hearts , 2002 .

[25]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[26]  E. Marbán,et al.  Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. , 2000, Circulation.

[27]  Yongge Liu,et al.  Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. , 2001, Molecular pharmacology.

[28]  V. Kupriyanov,et al.  Effects of K(ATP) channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts. , 2002, Journal of molecular and cellular cardiology.

[29]  David Y. Thomas,et al.  Localization of Endogenous Grb10 to the Mitochondria and Its Interaction with the Mitochondrial-associated Raf-1 Pool* , 1999, The Journal of Biological Chemistry.

[30]  G. Grover,et al.  Cardioprotection with the KATP Opener Cromakalim Is Not Correlated with Ischemic Myocardial Action Potential Duration , 1995, Journal of cardiovascular pharmacology.

[31]  A. Kowaltowski,et al.  Identification and Properties of a Novel Intracellular (Mitochondrial) ATP-sensitive Potassium Channel in Brain* , 2001, The Journal of Biological Chemistry.